How Ozempic works: why a diabetes shot makes people stop feeling hungry
Why Ozempic ran out: the GLP-1 drug shortage of 2022 to 2025
For up to three years, Ozempic, Wegovy, Mounjaro and Zepbound sat on the official list of drug shortages in the United States. The medicine already worked, and the companies wanted to sell more. So why could they not simply make more?
-
1
Miva's pharmacy was not the only one. In 2023, pharmacies in many places could not get enough of these pens.
-
2
In the United States, the FDA, the Food and Drug Administration, keeps an official list of drugs in shortage. Wegovy went on it in March 2022, Ozempic in August, and tirzepatide in December.
The rest of this episode is for subscribers
Subscribe to read every premium episode. You can cancel when you want.
Paid yearly: $99 instead of $119.88